Cargando…
Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?
Immunoparalysis, characterised by impairments in neutrophil and monocyte/macrophage function, is common in critically ill patients. The theoretical ability of granulocyte colony-stimulating factor (G-CSF) to improve the functions of both neutrophils and monocytes/macrophages provides a rationale for...
Autores principales: | Azoulay, Élie, Delclaux, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095052/ https://www.ncbi.nlm.nih.gov/pubmed/14593456 http://dx.doi.org/10.1007/s00134-003-2049-8 |
Ejemplares similares
-
How to treat severe infections in critically ill neutropenic patients?
por: Zafrani, Lara, et al.
Publicado: (2014) -
The strategy of antibiotic use in critically ill neutropenic patients
por: Legrand, Matthieu, et al.
Publicado: (2011) -
Risk factors for neutropenic fever in non- Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
por: Kim, Yu Ri, et al.
Publicado: (2021) -
EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN NON-NEUTROPENIC CANCER PATIENTS
por: Ibrahim, Ezzeldin M., et al.
Publicado: (1998) -
Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock
por: Schefold, Joerg C
Publicado: (2011)